1. Buck AK, Kratochwil C, Glatting G, Juweid M, Bommer M, Tepsic D, Vogg AT, Mattfeldt T, Neumaier B, Möller P, Reske SN. Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT. Eur. J. Nucl. Med. Mol. Imaging 2007; 34:1775-1782.
  2. Bunjes D, Glatting G, Neumaier B, Friesen C, Blumstein NM, Reske SN. Klinische Ergebnisse der Radioimmuntherapie: Radioimmunkonjugate in der Therapie von Leukämien. In: Trümper L, ed. Radioimmuntherapie in der Hämatologie und Onkologie. Bremen: UNI-MED SCIENCE, 2007; 56-68.
  3. Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, Wendl C, Bunjes D, Reske SN. Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience. Radiology 2007; 242:498-508.
  4. Ehrhardt AR, Reuter S, Buck AK, Haenle MM, Mason RA, Gabelmann A, Kern P, Kratzer W. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [18F]fluorodeoxyglucose positron emission tomography. Abdom. Imaging 2007; 32:730-735.
  5. Finter F, Mottaghy FM, Kuefer R, Hautmann RE, Rinnab L. Systemische Therapieansätze bei Knochenmetastasen urogenitaler Tumoren [Systemic therapy approaches in patients with bone metastases of urogenital malignancies]. Urologe 2007; 46:904-912.
  6. Friesen C, Glatting G, Koop B, Schwarz K, Morgenstern A, Apostolidis C, Debatin KM, Reske SN. Breaking chemo- and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells. Cancer Res. 2007; 67:1950-1958.
  7. Glatting G, Kletting P, Reske SN, Hohl K, Ring C. Choosing the optimal fit function: Comparison of the Akaike information criterion and the F-test. Med. Phys. 2007; 34:4285-4292.
  8. Glatting G, Lassmann M. Nuklearmedizinische Dosimetrie. In: Krause B-J, Schwaiger M, Buck AK, eds. Nuklearmedizinische Onkologie. 1. ed. Landsberg: Hüthig Jehle Rehm, 2007.
  9. Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann R, Spaepen K, Hicks RJ, Weber WA, Reske SN, Schwaiger M, Schwartz LH, Zijlstra JM, Siegel BA, Cheson BD. Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J. Clin. Oncol. 2007; 25:571-578.
  10. Kächele V, Pauls S, Mottaghy FM, Blumstein N, Brambs HJ, Barth TFE, Hannekum A, Höher M, Jeltsch M, Reske SN, Möller P, Adler G, Seufferlein T. A 25-year-old woman with gastric GIST and a PET-positive epicardial tumor. Nat. Clin. Pract. Oncol. 2007; 4:197-201.
  11. Koop B, Reske SN, Neumaier B. Labelling of a monoclonal antibody with 68Ga using three DTPA-based bifunctional ligands and their in vitro evaluation for application in radioimmunotherapy. Radiochim. Acta 2007; 95:39-42.
  12. Kratochwil C. The value of imaging techniques for bone metastases. Urologe A 2007; 46:891-896.
  13. Krüger S, Pauls S, Mottaghy FM, Buck AK, Schelzig H, Hombach V, Reske SN. Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma. Nuklearmedizin 2007; 46:239-243.
  14. Krüger S, Pauls S, Mottaghy FM, Kunze M, Marx N. Kardiale Sarkoidose mit AV-Block III. Grades - Diagnose mittels integriertem PET-CT [Cardiac sarcoidosis with 3rd degree AV block by means of integrated PET-CT]. Pneumologie 2007; 61:363-364.
  15. Krüger S, Kratochwil C, Schumann C, Wibmer T, Pauls S, Merk T. Primitive neuroectodermal tumour of the mediastinum as a rare cause of pericardial effusion. Pneumologie 2007; 61:801-802.
  16. Krüger S, Kratochwil C, Schumann C, Merk T, Wibmer T, Pauls S. Leiomyosarcoma of the diaphragm 20 years after resection of a diaphragmatic leiomyoma. Pneumologie 2007; 61:456-457.
  17. Kull T. 1.4 Strahlenschutz. In: Krause B-J, Schwaiger M, Buck AK, eds. Nuklearmedizinische Onkologie. 1. ed. Landsberg: Hüthig Jehle Rehm, 2007.
  18. Mottaghy FM, Sunderkötter C, Schubert R, Wohlfart P, Blumstein NM, Neumaier B, Glatting G, Özdemir C, Buck AK, Scharfetter-Kochanek K, Reske SN. Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma. Eur. J. Nucl. Med. Mol. Imaging 2007; 34:1355-1364.
  19. Neumaier B, Deisenhofer S, Fürst D, von Arnim CAF, Thees S, Buck AK, Glatting G, Landwehrmeyer GB, Krause BJ, Müller HD, Sommer C, Reske SN, Mottaghy FM. Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of a-amyloid plaques. Nuklearmedizin 2007; 26:271-280.
  20. Pauls S, Buck AK, Hohl K, Halter G, Hetzel M, Blumstein NM, Mottaghy FM, Glatting G, Krüger S, Sunder-Plassmann L, Möller P, Hombach V, Brambs H-J, Reske SN. Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT. Nuklearmedizin 2007; 46:9-14.
  21. Pauls S, Krüger S, Mottaghy FM. [18F]-FDG PET/CT bei paraneoplastischer Osteoarthropathie [18F-FDG PET/CT in paraneoplastic osteoarthropathy]. RöFo 2007; 179:80-82.
  22. Reske SN, Deisenhofer S, Glatting G, Zlatopolskiy BD, Morgenroth A, Vogg AT, Buck AK, Friesen C. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines. J. Nucl. Med. 2007; 48:1000-1007.
  23. Reske SN. Bildgebung des Prostatakarzinoms. Der Onkologe 2007; 13:677-690.
  24. Reske SN. Nuklearmedizinische Diagnostik beim Prostatakarzinom: Aktueller Stand [Nuclear Imaging of prostate cancer: Current status]. Urologe A 2007; 46:1485-1499.
  25. Reske SN, Dankerl A. PET and PET-CT in Multiple Myeloma. In: von Schulthess GK, ed. Molecular anatomic imaging: PET-CT and SPECT-CT integrated modality. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2007; 495-500.
  26. Rinnab L, Blumstein NM, Mottaghy FM, Hautmann RE, Küfer R, Hohl K, Reske SN. 11C-Choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer. BJU Int 2007; 99:1421-1426.
  27. Rinnab L, Mottaghy FM, Blumstein NM, Reske SN, Hautmann RE, Hohl K, Möller P, Wiegel T, Kuefer R, Gschwend JE. Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. BJU Int 2007; 100:786-793.
  28. Siedentopf CM, Ischebeck A, Haala I, Mottaghy FM, Schikora D, Verius M, Koppelstaetter F, Buchberger W, Schlager A, Felber SR, Golaszewski SM. Neural correlates of transmeatal cochlear laser (TCL) stimulation in healthy human subjects. Neurosci. Lett. 2007; 411:189-193.
  29. Thees S, Neumaier B, Glatting G, Deisenhofer S, von Arnim CAF, Reske SN, Mottaghy FM. Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humans. Nuklearmedizin 2007; 46:175-180.
  30. Vogg ATJ, Buck AK, Schmid M, Neumaier B, Wczasek K, Zlatopolskiy BD, Reske SN. Synthesis and biodistribution of 3’-fluoro-5-[131I]iodo-2’-deoxyuridine (FLIdU): a comparative study of [131I]FLIdU and [18F]FLT. Nucl. Med. Biol. 2007; 34:273-281.
  31. Weiss EM, Siedentopf CM, Golaszewski SM, Mottaghy FM, Hofer A, Kremser C, Felber SR, Fleischhacker WW. Brain activation patterns during a selective attention test - a functional MRI study in healthy volunteers and unmedicated patients during an acute episode of schizophrenia. Psychiatry Res. 2007; 154:31-40.
  32. Wöhrle J, Nusser T, Krause BJ, Kochs M, Habig T, Mottaghy FM, Kestler HA, Hombach V, Reske SN. Patients with in-stent restenoses. Comparison of intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter with the polymer-based paclitaxel-eluting taxus-express stent. Nuklearmedizin 2007; 46:185-191.